Could we be just two or three years away from curing cancer? Niven Narain, the president of Berg, a small Boston-based biotech firm, says that may very well be the case.
With funding from billionaire real-estate tycoon Carl Berg as well as from Mitch Gray, Narain, a medical doctor by training, and his small army of scientists, technicians, and programmers, have spent the last six years perfecting and testing an artificial intelligence platform that he believes could soon crack the cancer code, in addition to discovering valuable information about a variety of other terrible diseases, including Parkinson’s.
Thanks to partnerships formed with universities, hospitals, and even the U.S. Department of Defense, Berg and its supercomputers have been able to analyze thousands of patient records and tissue samples to find possible new drug targets and biomarkers.
All this data crunching has led to the development of Berg’s first drug, BPM…
View original post 1,635 more words